In patients with diabetic macular edema (DME) and BCVA of 20/50 or worse, treatment with faricimab may offer better outcomes than aflibercept with significantly fewer injections. Source: AAO
Aqueous tap with real-time polymerase chain reaction (RT-PCR) testing may not only help to identify pathogens associated with infectious uveitis, but also potentially aid clinicians in determining correct treatment options. Source: AAO
Filgotinib, an oral preferential Janus kinase 1 inhibitor, is currently approved to treat certain rheumatologic conditions in several countries outside the United States. The HUMBOLDT trial studied its potential efficacy in treating noninfectious uveitis. Source: AAO
Rates of postsurgical endophthalmitis are on the decline in the United States, a new fellowship will be training ophthalmologists in treating wartime injuries, and people who feel lonely or socially isolated may have an increased chance of developing glaucoma. Source: AAO
This prospective study assessed whether adjuvant use of the rho-kinase inhibitor netarsudil would improve the surgical outcomes of patients undergoing Descemet membrane stripping–only procedures. Source: AAO
Treatment with certain immunomodulator therapies could help reduce the risk of anterior uveitis in patients with axial spondyloarthritis. Source: AAO
Investigators studied the long-term proptosis reactivation/recurrence rate in patients who had completed a full course of teprotumumab treatment for active thyroid eye disease (TED). Source: AAO
According to a retrospective database study, patients with cutaneous keloids may to be more likely to develop postoperative proliferative vitreoretinopathy (PVR) than those without. Source: AAO
Dr. Stanislao Rizzo discussed the impressive performances of ChatGPT and Google Gemini in assessing cases of retinal detachment and suggesting surgical plans, as part of the Surgical Training Expert Panel at the ASRS 2024 Annual Meeting. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
